Terms: = Kidney tumors AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA
154 results:
1. SIRT7 promotes the proliferation and migration of anaplastic thyroid cancer cells by regulating the desuccinylation of KIF23.
Wu Y; Chen W; Miao H; Xu T
BMC Cancer; 2024 Feb; 24(1):210. PubMed ID: 38360598
[TBL] [Abstract] [Full Text] [Related]
2. Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis.
Rosellini M; Mollica V; Marchetti A; Coluccelli S; Giunchi F; Tassinari E; Ricci C; Fiorentino M; Tallini G; De Biase D; Massari F
Pathol Res Pract; 2024 Feb; 254():155142. PubMed ID: 38277752
[TBL] [Abstract] [Full Text] [Related]
3. Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/atm Inhibitors in Colorectal Cancer.
Zhang M; Li X; Herman JG; Gao A; Wang Q; Yao Y; Shen F; He K; Guo M
Clin Transl Gastroenterol; 2024 Mar; 15(3):e00682. PubMed ID: 38235705
[TBL] [Abstract] [Full Text] [Related]
4. Cancer predisposition signaling in Beckwith-Wiedemann Syndrome drives Wilms tumor development.
Nirgude S; Naveh NSS; Kavari SL; Traxler EM; Kalish JM
Br J Cancer; 2024 Mar; 130(4):638-650. PubMed ID: 38142265
[TBL] [Abstract] [Full Text] [Related]
5. RASSF1A promotes atm signaling and
Gao A; Bai P; Zhang M; Yao Y; Herman JG; Guo M
Epigenomics; 2023 Nov; 15(22):1205-1220. PubMed ID: 38093706
[No Abstract] [Full Text] [Related]
6. Decreased estimated glomerular filtration rate increase the risk of pancreatic cancer: A nationwide retrospective cohort study.
Shin S; Kim MH; Lee DY; Chun H; Ha E; Lee HC; Moon SH; Lee S; Ryoo JH
J Gastroenterol Hepatol; 2024 Feb; 39(2):392-398. PubMed ID: 37941163
[TBL] [Abstract] [Full Text] [Related]
7. Impact of High-to-Moderate Penetrance Genes on Genetic Testing: Looking over Breast Cancer.
Turchiano A; Piglionica M; Martino S; Bagnulo R; Garganese A; De Luisi A; Chirulli S; Iacoviello M; Stasi M; Tabaku O; Meneleo E; Capurso M; Crocetta S; Lattarulo S; Krylovska Y; Lastella P; Forleo C; Stella A; Bukvic N; Simone C; Resta N
Genes (Basel); 2023 Jul; 14(8):. PubMed ID: 37628581
[TBL] [Abstract] [Full Text] [Related]
8. Immunolocalization of the AT-1R Ang II Receptor in Human kidney Cancer.
Muscella A; Resta L; Cossa LG; Marsigliante S
Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627246
[TBL] [Abstract] [Full Text] [Related]
9. Inhibition of cMYC-MAX transcription factors hetero-dimerization with structurally engineered omoMYC to downregulate oncogenic pathways in renal carcinoma.
Li W; Bano F; Khan A; Wei DQ; Alshammari A; Xu B; Wang Y
Comput Biol Med; 2023 Sep; 164():107257. PubMed ID: 37527610
[TBL] [Abstract] [Full Text] [Related]
10. Performance of a Cell-Free DNA-Based Multi-cancer Detection Test in Individuals Presenting With Symptoms Suspicious for Cancers.
Bryce AH; Thiel DD; Seiden MV; Richards D; Luan Y; Coignet M; Zhang Q; Zhang N; Hubbell E; Kurtzman KN; Klein EA
JCO Precis Oncol; 2023 Jul; 7():e2200679. PubMed ID: 37467458
[TBL] [Abstract] [Full Text] [Related]
11. Relationships Between Urinary and Nonurinary Symptoms in Treatment-Seeking Women in LURN.
Smith AR; Mansfield SA; Bradley CS; Kenton KS; Helmuth ME; Cameron AP; Kirkali Z; Bretschneider CE; Andreev V; Sarma A; Lane G; Collins SA; Cella D; Lai HH; Harte SE; Griffith JW;
Urogynecology (Phila); 2024 Feb; 30(2):123-131. PubMed ID: 37428882
[TBL] [Abstract] [Full Text] [Related]
12. Late complications and 5 years outcomes of robotic partial nephrectomy in France: prospective assessment in the French kidney Cancer Research Network (UroCCR 10).
Margue G; Ingels A; Bensalah K; Doumerc N; Vaessen C; Roupret M; Audenet F; Mejean A; Bruyere F; Olivier J; Baumert H; Michel C; Paparel P; Parier B; Sebe P; Long JA; Lang H; Lebret T; Patard JJ; Bernhard JC
World J Urol; 2023 Aug; 41(8):2281-2288. PubMed ID: 37407720
[TBL] [Abstract] [Full Text] [Related]
13. Transperitoneal Versus Retroperitoneal Single-port Robotic-assisted Partial Nephrectomy: An Analysis from the Single Port Advanced Research Consortium.
Rich JM; Okhawere KE; Nguyen C; Ucpinar B; Zuluaga L; Razdan S; Saini I; Tuna Beksac A; Nguyen J; Calvo RS; Ahmed M; Mehrazin R; Abaza R; Stifelman MD; Kaouk J; Crivellaro S; Badani KK
Eur Urol Focus; 2023 Nov; 9(6):1059-1064. PubMed ID: 37394396
[TBL] [Abstract] [Full Text] [Related]
14. Analysis of clinical characteristics and prognostic factors of elderly patients with renal cell carcinoma based on the SEER database.
Peng X; Sun H; Wang L; Guo W; Zhao Z; Yang J
Medicine (Baltimore); 2023 Jun; 102(25):e34069. PubMed ID: 37352082
[TBL] [Abstract] [Full Text] [Related]
15. Automatic tube compensation for liberation from prolonged mechanical ventilation in tracheostomized patients: A retrospective analysis.
Wu CH; Lin FC; Jerng JS; Shin MH; Wang YC; Lee CJ; Lin LM; Lin NH; Kuo YW; Ku SC; Wu HD
J Formos Med Assoc; 2023 Nov; 122(11):1132-1140. PubMed ID: 37169656
[TBL] [Abstract] [Full Text] [Related]
16. Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines.
Dillman RO; Nistor GI; Keirstead HS
Hum Vaccin Immunother; 2023 Dec; 19(1):2198467. PubMed ID: 37133853
[TBL] [Abstract] [Full Text] [Related]
17. Adaptive Immunity in Genitourinary Cancers.
Koti M; Bivalacqua T; Black PC; Cathomen T; Galsky MD; Gulley JL; Ingersoll MA; Kamat AM; Kassouf W; Siemens DR; Gao J
Eur Urol Oncol; 2023 Jun; 6(3):263-272. PubMed ID: 37069029
[TBL] [Abstract] [Full Text] [Related]
18. Pan-cancer antagonistic inhibition pattern of atm-driven G2/M checkpoint pathway vs other DNA repair pathways.
Zolotovskaia MA; Modestov AA; Suntsova MV; Rachkova AA; Koroleva EV; Poddubskaya EV; Sekacheva MI; Tkachev VS; Garazha AV; Glusker AA; Seryakov AP; Vladimirova US; Rumiantsev PO; Moisseev AA; Zharkov DO; Kuzmin DV; Zhao X; Prassolov VS; Shegay PV; Li X; Steinbichler TB; Kim E; Sorokin MI; Wang Y; Buzdin AA
DNA Repair (Amst); 2023 Mar; 123():103448. PubMed ID: 36657260
[TBL] [Abstract] [Full Text] [Related]
19. The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk.
Yang Y; Zhang G; Hu C; Luo W; Jiang H; Liu S; Yang H
BMC Urol; 2022 Nov; 22(1):196. PubMed ID: 36451132
[TBL] [Abstract] [Full Text] [Related]
20. A novel nomogram and risk classification system predicting the overall survival of patients with papillary renal cell carcinoma after nephrectomy: A population-based study.
Hu Y; Xu S; Qi Q; Wang X; Meng J; Zhou J; Hao Z; Liang Q; Feng X; Liang C
Front Public Health; 2022; 10():989566. PubMed ID: 36276376
[TBL] [Abstract] [Full Text] [Related]
[Next]
